NEWS
Tags: 

GenoLogics receives second round of funding

GenoLogics, a developer of lab and scientific data management solutions, has completed a second round of financing led by OVP Venture Partners in Seattle, together with Growth Works and Yaletown Venture Partners. This round of financing will allow the company to accelerate its systems biology market penetration strategy.

This financing round dovetails with the introduction of GenoLogics' latest product, Geneus, which targets the lab and data management segment of the genomics market. These funds will enable GenoLogics to accelerate the development of Geneus and respond faster to the myriad of emerging genomics and systems biology opportunities that are surfacing.

Dr Rick LeFaivre, partner at OVP Venture Partners, commented: 'We firmly believe that GenoLogics has significant market opportunity and we are committed to helping the company become another success story.'

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

David Wang gives his view on how modern laboratories can leverage data to provide maximum value

Feature

Elsevier’s Jabe Wilson predicts radical changes in the ways AI will be used in scholarly communications

Feature

Robert Roe looks at advances in automotive simulation

Feature

Sophia Ktori reveals the informatics company’s history – and plans for the future

Feature

Robert Roe reports from the SC17 conference keynote, detailing progress on the Square kilometre Array project